VALBIOTIS (EPA:ALVAL) | WebDisclosure

Basculer en Français

9784	Companies
196020	Keywords
127081	Articles
104247	Press releases

Home
Companies
VALBIOTIS

PRESS RELEASE

published on 06/20/2024 at 08:50, 1 year 7 months ago

Valbiotis : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Mai 2024
Rapport mensuel sur le nombre total d'actions et de droits de vote de Valbiotis conforme à l'article 223-16 du RG de l'AMF. Valbiotis, laboratoire français spécialisé en compléments alimentaires pour la santé cardiovasculaire

Capital Social AMF Valbiotis Compléments Alimentaires Santé Cardiovasculaire
PRESS RELEASE

published on 06/20/2024 at 08:50, 1 year 7 months ago

Valbiotis : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Mai 2024
Valbiotis communique les informations mensuelles sur le nombre de droits de vote et d'actions en mai 2024. L'entreprise est spécialisée dans les compléments alimentaires pour la santé cardiovasculaire

Droits De Vote Capital Social Valbiotis Compléments Alimentaires Troubles Métaboliques
BRIEF

published on 06/17/2024 at 17:45, 1 year 7 months ago

Valbiotis présentera aux sessions de l’American Diabetes Association

Valbiotis Compléments Alimentaires American Diabetes Association TOTUM•63 Diabète
BRIEF

published on 06/17/2024 at 17:45, 1 year 7 months ago

Valbiotis to present at American Diabetes Association sessions

Diabetes Valbiotis American Diabetes Association TOTUM•63 Food Supplements
PRESS RELEASE

published on 06/17/2024 at 17:40, 1 year 7 months ago

Valbiotis sélectionnée aux 84èmes sessions scientifiques de l’American Diabetes Association
Valbiotis sélectionnée pour présenter les résultats cliniques de la Phase II/III REVERSE-IT de TOTUM•63 lors des 84èmes sessions scientifiques de l’American Diabetes Association

Valbiotis Prevention American Diabetes Association TOTUM•63 Diabète De Type 2
PRESS RELEASE

published on 06/17/2024 at 17:40, 1 year 7 months ago

Valbiotis invited to present clinical results at the American Diabetes Association’s 84th Scientific Sessions
Valbiotis invited to present clinical results from TOTUM•63 Phase II/III REVERSE-IT study in prediabetes and type 2 diabetes at the American Diabetes Association’s 84th Scientific Sessions

Valbiotis American Diabetes Association TOTUM•63 Clinical Results Scientific Sessions
BRIEF

published on 06/06/2024 at 10:58, 1 year 7 months ago

Valbiotis Terminate Licensing Agreement with Nestlé Health Science

Licensing Agreement Valbiotis Diabetes Treatment TOTUM•63 Nestlé Health Science
BRIEF

published on 06/06/2024 at 10:58, 1 year 7 months ago

Valbiotis met fin à son accord de licence avec Nestlé Health Science

Valbiotis TOTUM•63 Traitement Du Diabète Contrat De Licence Nestlé Sciences De La Santé
PRESS RELEASE

published on 06/06/2024 at 10:53, 1 year 7 months ago

Valbiotis reaches an agreement to terminate its licensing and supply agreement with Nestlé Health Science
Valbiotis regains full ownership of TOTUM•63, a plant-based dietary supplement for prediabetes and early type 2 diabetes, after terminating agreement with Nestlé Health Science

Valbiotis Dietary Supplement TOTUM•63 Nestlé Health Science Prediabetes
BRIEF

published on 06/06/2024 at 10:49, 1 year 7 months ago

Valbiotis et Nestlé Health Science mettent fin à leur contrat de licence et d’approvisionnement

Valbiotis Compléments Alimentaires Propriété Intellectuelle TOTUM•63 Nestlé

Accesswire

Published on 02/02/2026 at 23:55, 7 hours 21 minutes ago

2026 Tunkillia Development Drilling Programs Begin
Published on 02/02/2026 at 23:55, 7 hours 21 minutes ago

55 North Mining Announces Winter Exploration Drill Program at Last Hope Gold Project
Published on 02/02/2026 at 23:25, 7 hours 51 minutes ago

Western Announces Sale of GlassMasters Investment
Published on 02/02/2026 at 22:05, 9 hours 11 minutes ago

Organto Foods to Attend Fruit Logistica 2026 in Berlin, Germany From February 4-6, 2026
Published on 02/02/2026 at 15:00, 16 hours 16 minutes ago

Jericho Energy Ventures Strategically Terminates SmartKem LOI to Advance Independent Data Center Energy Infrastructure Platform

View all ACCESSWIRE

EQS Group

Published on 02/03/2026 at 07:00, 15 minutes ago

Siltronic AG with preliminary financial figures: Targets for 2025 achieved despite challenging conditions
Published on 02/03/2026 at 07:00, 15 minutes ago

Sartorius Stedim Biotech réalise une croissance rentable importante en 2025 et maintient des perspectives positives
Published on 02/03/2026 at 07:00, 15 minutes ago

Sartorius Stedim Biotech achieves considerable profitable growth in 2025 and maintains positive outlook
Published on 02/03/2026 at 07:00, 15 minutes ago

Medacta Group SA: Medacta Group reports continued significant above-market revenue growth of 18.5% in constant currency in 2025
Published on 02/03/2026 at 07:00, 16 minutes ago

Sartorius achieves considerable profitable growth in 2025 and maintains positive outlook

Les Echos

Published on 02/02/2026 at 18:23, 12 hours 52 minutes ago

Monthly disclosure of the total number of shares and voting rights - January 2026
Published on 02/02/2026 at 18:23, 12 hours 52 minutes ago

TF1 - Déclaration mensuelle des actions et droits de vote - Janvier 2026
Published on 02/02/2026 at 18:00, 13 hours 16 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 02/02/2026 at 18:00, 13 hours 16 minutes ago

Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 02/02/2026 at 18:00, 13 hours 16 minutes ago

Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social

View all LES ECHOS COMFI WIRE